Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal Function

Trial Profile

Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal Function

Recruiting
Phase of Trial: Phase I

Latest Information Update: 05 Apr 2018

At a glance

  • Drugs Nemonoxacin
  • Indications Renal impairment
  • Focus Pharmacodynamics
  • Sponsors Zhejiang Medicine
  • Most Recent Events

    • 01 Apr 2018 Planned End Date changed from 1 Sep 2017 to 1 Jan 2019.
    • 01 Apr 2018 Planned primary completion date changed from 1 Aug 2017 to 1 Jan 2019.
    • 01 Apr 2018 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top